Pharmacy Times August 8, 2025
In an interview with Pharmacy Times®, Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA discusses the potential implications of rising Medicare Part D premiums, emphasizing the uncertainty surrounding how these changes will ultimately impact patients and health systems. While the full effects remain speculative, existing adherence literature shows that even minor increases in copays—sometimes as little as five or six dollars—can lead patients to stop taking their medications.
Soefje notes that oncology pharmacists, in particular, may face difficult decisions about whether to continue high-cost medications or switch patients to potentially less effective alternatives. As more patients may rely on assistance programs, pharmacists are likely to be drawn into navigating manufacturer support processes, especially in health systems without established infrastructures. The overarching...
Today's Sponsors
Today's Sponsor